News

The goal of this grant is to provide scientific leadership and infrastructure for laboratory testing as part of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.

Designed by Zimmer Gunsul Frasca Architects (ZGF), the three-story, 45,000-square-foot building is an apt tribute to its prominent, coastal location, with its long, slender shape. Exposed architectural concrete

Specifically, the patent, which expires in 2025 without taking into account patent term extension, provides proprietary protection for methods of treating chronic inflammation by administration of modified pectin

The agreement provides for a combination of upfront, research and milestone payments. Under the agreement, the two companies will work together to identify disease-associated pathways and targets for

The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder. AstraZeneca Screening Sciences and Sample Management vice president Steve

Pursuant to the MTA, Revive Therapeutics will obtain access to confidential information and clinical trial supply of the drug bucillamine for Revive Therapeutics’ human clinical trial of REV-002,

The COAST (Patients with Stage IV COlorectal Cancer treated with Adjuvant Regorafenib Versus Placebo after Curative Treatment of Liver Metastases in A Randomized, Double-blind, Placebo-controlled Phase-III Study) clinical

The company said that FTI, a combination of fosfomycin and tobramycin, is ready for Phase III clinical trials, having completed a Phase II trial in CF patients. FTI

In conjunction with the licensing deal, BioMotiv has established Kodosil Bio which will develop all compounds resulting from the license. BioAtla president and CEO Jay Short said the